Canada’s device agency plans to issue guidance on machine learning, and the FDA plans to release a draft guidance next year on lifecycle management and premarket submissions for AI devices.
FDA, Health Canada give sneak peek into future AI regs Read More »
Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.
AI Is Accelerating Biopharma Innovation But Not Erasing a Human’s Touch Read More »
Wave Life Sciences in a Tuesday filing with the SEC said Takeda has elected to terminate its option to continue work on Wave’s WVE-003 clinical-stage Huntington’s disease program—a potential $5 billion commercial opportunity, according to the biotech.
Jazz Pharmaceuticals contends that its alkylating agent Zepzelca significantly improved both overall survival and progression-free survival in patients with extensive-stage small cell lung cancer, when used as a front-line maintenance therapy with Roche’s Tecentriq.
Jazz Touts Survival Benefit for First-Line Maintenance Therapy in SCLC Read More »
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and respiratory syncytial virus shot mResvia.
GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines Read More »
Johnson & Johnson is cutting several programs—most of which are in neurology and psychiatry—as the company also pulls back from the infectious diseases market.
J&J Scraps Pipeline Assets Including Alzheimer’s and Parkinson’s Candidates Read More »
Sanofi looks to follow a deep history of Big Pharmas offloading their consumer healthcare businesses.
Un reciente estudio desvela aspectos clave sobre el enigmático Amphimoschus, un rumiante que vivió en Europa durante el Mioceno, hace entre 17,5 millones de años y 13,8 millones. El estudio también aporta información sobre la evolución de los apéndice …
Aclaran misterios sobre la evolución de los rumiantes Read More »
Se ha presentado públicamente la primera pieza terminada del colosal mapa del universo que está siendo confeccionado a partir de las observaciones del satélite astronómico Euclid de la Agencia Espacial Europea (ESA). Este primer fragmento del mapa, que es un enor …
Completado el primer fragmento del colosal mapa del universo de la misión Euclid Read More »
J&J beat expectations this week to launch the Q3 earnings season; a study about children treated with bluebird bio’s Skysona comes at a bad time for the company; Sen. Warren calls for scrutiny of Novo’s purchase of Catalent; and other news.
